The authors described a significant correlation between higher CBX2 and lower CBX7 mRNA levels and worse BC prognosis, which agrees with previous findings that correlated the CBX2 or CBX7 expression with overall patient survival [127,128,129,130]. Here, CBX2 is linked to breast cancer.